title: Treatment Patterns and Costs Of Neoadjuvant Systemic Therapies (NAT) For Early Breast Cancer (EBC): A Retrospective Claims Analysis.
authors.affiliation: IMS Health, Alexandria, VA, USA.
authors.forename: Y J
authors.initials: YJ
authors.lastname: Chen
authors.affiliation: Genentech, Inc., South San Francisco, CA, USA.
authors.forename: E
authors.initials: E
authors.lastname: Santos
authors.affiliation: IMS Health, Alexandria, VA, USA.
authors.forename: V
authors.initials: V
authors.lastname: Schabert
authors.affiliation: Genentech, Inc., South San Francisco, CA, USA.
authors.forename: V P
authors.initials: VP
authors.lastname: Antao
authors.affiliation: IMS Health, Alexandria, VA, USA.
authors.forename: A P
authors.initials: AP
authors.lastname: De
authors.affiliation: Genentech, Inc., South San Francisco, CA, USA.
authors.forename: C C
authors.initials: CC
authors.lastname: Portera
authors.affiliation: IMS Health, Alexandria, VA, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Genentech, Inc., South San Francisco, CA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Kamath